(Q42195030)

18 October 2017

0 references

Neurological functions of the masterswitch protein kinase - gsk-3. (English)

1 reference

18 October 2017

2

1 reference

18 October 2017

4

1 reference

PMCID

3321477

Oksana Kaidanovich-Beilin

18 October 2017

object named as

Oksana Kaidanovich-Beilin

series ordinal

1

0 references

author name string

Richard Scott Jope

series ordinal

3

1 reference

18 October 2017

9 April 2012

1 reference

Frontiers in Molecular Neuroscience

18 October 2017

1 reference

18 October 2017

5

1 reference

18 October 2017

48

1 reference

GSK-3β and memory formation

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

AKT/GSK3 signaling pathway and schizophrenia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Inhibition of GSK3 by lithium, from single molecules to signaling networks

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

A pivotal role of GSK-3 in synaptic plasticity.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK3 as a Sensor Determining Cell Fate in the Brain

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Role of GSK3 Signaling in Neuronal Morphogenesis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Functions of GSK-3 Signaling in Development of the Nervous System.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK-3: Functional Insights from Cell Biology and Animal Models

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK3 and Alzheimer's Disease: Facts and Fiction….

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Glycogen synthase kinase-3 in the etiology and treatment of mood disorders

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3321477

17 August 2018

Identifiers

DOI

10.3389/FNMOL.2012.00048

1 reference

18 October 2017

1 reference

18 October 2017

1 reference

PMCID

3321477